Literature DB >> 10048970

Risk factors for prostate cancer: a case-control study in Greece.

C C Hsieh1, A Thanos, D Mitropoulos, C Deliveliotis, C S Mantzoros, D Trichopoulos.   

Abstract

A case-control study of prostate cancer (PC) was undertaken in Athens, Greece. Cases were 320 patients with histologically confirmed incident disease, whereas controls were 246 patients without history or symptomatology of benign prostatic hyperplasia, treated in the same hospitals as the cases for minor diseases or conditions. Cases and controls had similar distributions with respect to height, body mass index, sibship size and birth order in the parental family, marital status and number of offspring in the subject's own family and a long series of previous surgical operations and medical diagnoses, including diabetes mellitus, hepatitis and sexually transmitted diseases. There was also no evidence for a positive association between vertex baldness, tobacco smoking and drinking of coffee or alcoholic beverages, on the one hand, and PC, on the other. There was evidence, however, that some aspect of urban life may increase the risk for PC and a suggestion that sexual activity in early adulthood may be inversely associated with this risk.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10048970     DOI: 10.1002/(sici)1097-0215(19990301)80:5<699::aid-ijc12>3.0.co;2-7

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  30 in total

1.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

2.  No association between polymorphism in the vascular endothelial growth factor gene at position -460 and sporadic prostate cancer in the Turkish population.

Authors:  Ilke H Onen; Ece Konac; Muzaffer Eroglu; Cagri Guneri; Hasan Biri; Abdullah Ekmekci
Journal:  Mol Biol Rep       Date:  2007-01-11       Impact factor: 2.316

3.  Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study.

Authors:  Kathryn M Wilson; Julie L Kasperzyk; Jennifer R Rider; Stacey Kenfield; Rob M van Dam; Meir J Stampfer; Edward Giovannucci; Lorelei A Mucci
Journal:  J Natl Cancer Inst       Date:  2011-05-17       Impact factor: 13.506

4.  Male pattern baldness in relation to prostate cancer risks: an analysis in the VITamins and lifestyle (VITAL) cohort study.

Authors:  Cindy Ke Zhou; Alyson J Littman; Paul H Levine; Heather J Hoffman; Sean D Cleary; Emily White; Michael B Cook
Journal:  Prostate       Date:  2014-12-09       Impact factor: 4.104

5.  Relationship of early-onset baldness to prostate cancer in African-American men.

Authors:  Charnita Zeigler-Johnson; Knashawn H Morales; Elaine Spangler; Bao-Li Chang; Timothy R Rebbeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-26       Impact factor: 4.254

6.  Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case-control series of veterans.

Authors:  Jean-Alfred Thomas; Jodi A Antonelli; Lionel L Banez; Catherine Hoyo; Delores Grant; Wendy Demark-Wahnefried; Elizabeth A Platz; Leah Gerber; Kathryn Shuler; Enwono Eyoh; Elizabeth Calloway; Stephen J Freedland
Journal:  Cancer Causes Control       Date:  2013-03-26       Impact factor: 2.506

7.  CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.

Authors:  Gang Ding; Weiguo Xu; Hedai Liu; Ming Zhang; Qian Huang; Zhijun Liao
Journal:  Mol Biol Rep       Date:  2013-03-09       Impact factor: 2.316

Review 8.  Inflammation and prostate cancer: a focus on infections.

Authors:  Siobhan Sutcliffe; Elizabeth A Platz
Journal:  Curr Urol Rep       Date:  2008-05       Impact factor: 3.092

9.  Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis.

Authors:  Luisa Zuccolo; Ross Harris; David Gunnell; Steven Oliver; Jane Athene Lane; Michael Davis; Jenny Donovan; David Neal; Freddie Hamdy; Rebecca Beynon; Jelena Savovic; Richard Michael Martin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

Review 10.  Prostate cancer: is it time to expand the research focus to early-life exposures?

Authors:  Siobhan Sutcliffe; Graham A Colditz
Journal:  Nat Rev Cancer       Date:  2013-01-31       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.